Immobilized Human Siglec2 at 0.5 μg/ml (100 μl/Well). Dose response curve for Biotinylated Anti-Siglec2 Ab with the EC50 of 0.2 μg/ml determined by ELISA.
Recombinant Siglec-2/CD22 on SDS-PAGE under reducing conditions. The purity is greater than 95%.
The purity of Siglec-2/CD22 is greater than 95% as determined by SEC-HPLC
Immobilized Siglec-2/CD22, hFc, Human, hFc Tag at 2 μg/ml(100 μL/well) on the plate. Dose response curve for Biotinylated Anti-Siglec-2 Antibody, hFc Tag with the EC50 of 14.9 ng/ml determined by ELISA.
The purity of Siglec-2/CD22, hFc, Human is greater than 95% as determined by SEC-HPLC
Siglec-2/CD22, hFc, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.
Siglec-2/CD22, hFc, Human
CD22, or cluster of differentiation-22, is a molecule belonging to the SIGLEC family of lectins. It is found on the surface of mature B cells and to a lesser extent on some immature B cells. CD22 a member of the immunoglobulin superfamily. CD22 functions as an inhibitory receptor for B cell receptor (BCR) signaling. It is also involved in the B cell trafficking to Peyer's patches in mice.
| Z03643 | |
|
|
|
| ￥1760 | |
|
|
|
|
|
|
| 联系我们 | |
